Dexcom shares plummet more than 30% after company lowers fiscal year guidance

The Dexcom logo is seen on a smartphone screen and in the background.

Pavlo Gonchar | SOPA Images | Lightrocket | Getty Images

Shares of Dexcom tumbled more than 33% in after-hours trading Thursday after the diabetes management company reported disappointing revenue for the second quarter and offered weak guidance.

Here’s how the company did:

Earnings per share: 43 cents adjusted vs. 39 cents expected by LSEG
Revenue: $1 billion vs. $1.04 billion expected by LSEG

Dexcom’s revenue increased 15% from $871.3 million a year earlier, according to a release.

This is breaking news. Please refresh for updates.

Source

Technology

Anthropic loses appeals court bid to temporarily block Pentagon blacklisting

April 8, 2026

New York Times columnist Andrew Ross Sorkin and CEO and co-founder of Anthropic Dario Amodei speak onstage during the 2025 New York Times Dealbook Summit at Jazz at Lincoln Center in New York, Dec. 3, 2025. Michael M. Santiago | Getty Images A federal appeals court in Washington, D.C., on Wednesday denied Anthropic’s request for […]

Technology

OpenAI will allocate IPO shares to retail investors as it preps for debut, CFO says

April 8, 2026

Sarah Friar, CFO of OpenAI, speaking on CNBC’s Squawk Box at the World Economic Forum in Davos, Switzerland on Jan. 21st, 2026. Oscar Molina | CNBC OpenAI plans to reserve a portion of shares for individual investors in what’s expected to be a blockbuster initial public offering. Chief Financial Officer Sarah Friar told CNBC that […]

Technology

Latest investigation of Bitcoin founder ties identity to Blockstream CEO Adam Back

April 8, 2026

Adam Back, co-founder and chief executive officer of Blockstream, during the Bitcoin 2025 conference in Las Vegas, Nevada, US, on Wednesday, May 28, 2025. Ronda Churchill | Bloomberg | Getty Images A report in the New York Times claims it has discovered the identity of the pseudonymous creator of Bitcoin known as Satoshi Nakamoto. The […]